The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Diet, lifestyle, and the risk of type 2 diabetes mellitus in women.
Hu, F. B., Manson, J. E., Stampfer, M. J., Colditz, G., Liu, S., Solomon, C. G., & Willett, W. C. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010492 · Cited by 2,901
Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743
Reaven, G. M., Lithell, H., & Landsberg, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602083340607 · Cited by 1,435
Buchanan, T. A., Xiang, A. H., Peters, R. K., Kjos, S. L., Marroquin, A., Goico, J., Ochoa, C., Tan, S., Berkowitz, K., Hodis, H. N., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2796 · Cited by 1,339
Eriksson, K. F., & Lindg�rde, F. (1991) · Diabetologia · doi:10.1007/bf00400196 · Cited by 1,092
Kiddy, D. S., Hamilton‐Fairley, D., Bush, A., Short, F., Anyaoku, V., Reed, M. J., & Franks, S. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02909.x · Cited by 921
Research works printed but not linked: 32
- Haffner, 1992, Prospective analysis of the insulin-resistance syndrome (syndrome X), Diabetes, 41, 715, 10.2337/diabetes.41.6.715 · DOI
- Trovisan, 1998, Syndrome X and mortality a population-based study, Am J Epidemiol, 14B, 958, 10.1093/oxfordjournals.aje.a009572 · DOI · Paper page
- Ford, 2002, Prevalence of the metabolic syndrome among US adults, JAMA, 287, 356, 10.1001/jama.287.3.356 · DOI · Paper page
- Grundy, 1999, Hypertriglyceridemia, insulin resistance, and the metabolic syndrome, Am J Cardiol, 83, 25F, 10.1016/S0002-9149(99)00211-8 · DOI · Paper page
- Hansson, 1998, Therapy of hypertension and metabolic syndrome, Blood Press, 20, 10.1080/080370598438438 · doi:10.1080/080370598438438
- Moller, 2001, New drug targets for type 2 diabetes and the metabolic syndrome, Nature, 414, 821, 10.1038/414821a · DOI · Paper page
- Pasquali, 1999, The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment, Clin Endocinol, 50, 517, 10.1046/j.1365-2265.1999.00701.x · DOI · Paper page
- Glueck, 1999, Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome, Metabolism, 48, 511, 10.1016/S0026-0495(99)90113-0 · DOI · Paper page
- Knochenhauer, 1998, Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States, J Clin Endocrinol Metab, 83, 3078, 10.1210/jc.83.9.3078 · DOI · Paper page
- Fleming, 2002, Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double-blind, placebo-controlled trial, J Clin Endocrinol Metab, 87, 569, 10.1210/jc.87.2.569 · DOI · Paper page
- Glueck, 1999, Contribution of fasting hyperinsulinemia to prediction of atherosclerotic cardiovascular disease in 239 hyperlipidemic patients, Metabolism, 48, 1427, 10.1016/S0026-0495(99)90156-7 · DOI
- Glueck, 2002, Pregnancy outcomes among women with polycystic ovary syndrome, Hum Reprod, 17, 2858, 10.1093/humrep/17.11.2858 · DOI · Paper page
- Glueck, 2002, Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome, Fertil Steril, 77, 520, 10.1016/S0015-0282(01)03202-2 · DOI · Paper page
- Ferriman, 1961, Clinical Assessment of body hair growth in women, J Clin Endocrinol Metab, 21, 1440, 10.1210/jcem-21-11-1440 · DOI · Paper page
- Lobo, 2000, The importance of diagnosing the polycystic ovary syndrome, Ann Intern Med, 132, 989, 10.7326/0003-4819-132-12-200006200-00010 · DOI · Paper page
- Talbott, 1995, Coronary heart disease risk factors in women with polycystic ovary syndrome, Arterioscl Thromb Vasc Biol, 15, 821, 10.1161/01.ATV.15.7.821 · DOI · Paper page
- Talbott, 2001, Cardiovascular risk in women with polycystic ovary syndrome, Ob Gyn Clin N Am, 28, 111, 10.1016/S0889-8545(05)70189-3 · DOI
- Loucks, 2000, Do polycystic ovaries affect the risk of cardiovascular disease among women with polycystic ovary syndrome?, Fert Steril, 74, 547, 10.1016/S0015-0282(00)00695-6 · DOI
- Paradisi, 2001, Polycystic ovary syndrome is associated with endothelial dysfunction, Circulation, 103, 1410, 10.1161/01.CIR.103.10.1410 · DOI · Paper page
- Yarali, 2001, Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome, Fertil Steril, 76, 511, 10.1016/S0015-0282(01)01937-9 · DOI · Paper page
- Diamanti-Kandarakis, 2001, Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy, J Clin Endocrinol Metab, 86, 4666, 10.1210/jc.86.10.4666 · DOI
- Guzick, 1996, Carotid atherosclerosis in women with polycystic ovary syndrome, Am J Obstet Gynecol, 174, 1224, 10.1016/S0002-9378(96)70665-8 · DOI · Paper page
- Dahlgren, 1992, Polycystic ovary syndrome and risk for myocardial infarction, Acta Obstet Gynecol Scand, 71, 559, 10.3109/00016349209006227 · DOI · Paper page
- Legro, 2002, Self-selected women with polycystic ovary syndrome are reproductively and metabolically abnormal and undertreated, Fertil Steril, 78, 51, 10.1016/S0015-0282(02)03153-9 · DOI
- Korhonen, 2001, Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome, Am J Obstet Gynecol, 184, 289, 10.1067/mob.2001.109596 · DOI
- Pan, 1997, Effects of diet and exercise in prevention NIDDM in people with impared glucose tolerance, Diabetes Care, 20, 537, 10.2337/diacare.20.4.537 · DOI · Paper page
- Freemark, 2001, Effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes, Pediatrics, 107, E55, 10.1542/peds.107.4.e55 · DOI · Paper page
- Kay, 2001, Beneficial effects of metformin in morbidly obese adolescents, Metabolism, 50, 1457, 10.1053/meta.2001.28078 · DOI · Paper page
- Glueck, 2002, Treatment of polycystic ovary syndrome with insulin-lowering agents, Exp Opin Pharmacother, 3, 177
- Despres, 1996, Hyperinsulinemia as an independent risk factor for ischemic heart disease, N Engl J Med, 334, 952, 10.1056/NEJM199604113341504 · DOI · Paper page
- Folsom, 1997, A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes, Diabetes Care, 209, 935, 10.2337/diacare.20.6.935 · DOI · Paper page
- Kuusisto, 2001, Insulin resistance syndrome predicts coronary heart disease events in elderly type 2 diabetic men, Diabetes Care, 24, 1629, 10.2337/diacare.24.9.1629 · DOI
Cited by
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132
Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.57 · Cited by 2,005
Ehrmann, D. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041536 · Cited by 1,881
Moran, L. J., Misso, M. L., Wild, R. A., & Norman, R. J. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq001 · Cited by 1,108
Metadata
- Authors
- Glueck, C. J., Papanna, R., Wang, P., Goldenberg, N., & Sieve-Smith, L.
- Venue
- Metabolism
- Publisher
- Elsevier BV
- Published
- 2003-07
- Volume
- 52
- Issue
- 7
- Pages
- 908-915
- ISSN
- 0026-0495 (ISSN-L)
- OpenAlex
- W2067094952
- Cited by
- 399
- References
- 15
- FWCI
- 18.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome. https://app.cochat.ai/papers/10.1016/s0026-0495(03)00104-5
- The paper
- Glueck, C. J., Papanna, R., Wang, P., Goldenberg, N., & Sieve-Smith, L. (2003). Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome. Metabolism. https://doi.org/10.1016/s0026-0495(03)00104-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.